SS-31 2S50 50mg x 10 Vials
Product Overview
SS-31 2S50 is a high-concentration formulation in the SS-31 mitochondrial-targeted antioxidant peptide series, representing an upgraded version surpassing the basic 2S10 and intermediate 2S20 specifications. As a cell-permeable endogenous tetrapeptide (Elamipretide), it possesses precise cardiolipin binding properties, high mitochondrial selective accumulation, zero immunogenicity, and high biochemical stability. The 50mg high-concentration dose exceeds the efficacy saturation range of traditional medium-dose SS-31 products, supporting research on cardiolipin binding in the mitochondrial inner membrane, respiratory chain supercomplex structure stabilization, and severe oxidative stress damage intervention. It supports research on mitochondrial reconstruction, multi-organ damage repair, and anti-aging protection that exceeds low-dose and medium-dose formulation ranges. 2S50 is designed for severe mitochondrial damage modeling, ischemia-reperfusion injury intervention, advanced neurodegenerative disease and severe cardiovascular injury studies, high-intensity oxidative stress limit experiments, and complex peptide-assisted organ protection structure validation, serving as an advanced preclinical research material for mitochondrial pathophysiology and severe degenerative disease pharmacology research.
Core Research Functions
Cardiolipin Anchoring and Mitochondrial Structure Support: Supports saturated cardiolipin anchoring research and damaged mitochondrial cristae structure repair studies.
Endogenous ROS Source Blocking: Supports endogenous reactive oxygen species (ROS) source blocking research and severe persistent oxidative cascade damage intervention studies.
Respiratory Chain Optimization: Supports respiratory chain optimization research and ATP energy synthesis efficiency enhancement studies.
Oxidative Apoptosis Inhibition: Supports severe oxidative-induced apoptosis inhibition research and irreversible tissue damage intervention studies.
Multi-Organ Mitochondrial Protection: Supports multi-organ mitochondrial protection research and late-stage degenerative aging intervention studies.
2S50 50mg offers efficacy exceeding the balanced moderate potency of 2S20, supporting research on instantaneous strong efficacy, long-lasting full-load protection, and severe mitochondrial damage intervention that exceeds conventional high-dose regimen ranges. It targets research on refractory severe mitochondrial damage, end-stage energy metabolic failure, advanced neuronal and cardiomyocyte degeneration, and extreme oxidative stress damage that show limited response to conventional high-dose regimens. It supports research on disintegrated mitochondrial cristae structure repair, membrane potential balance stabilization, large-scale ROS production blocking, and cellular energy cycle efficiency enhancement. It supports research on myocardial ischemia-reperfusion injury, severe neurooxidative degeneration, and multi-organ mitochondrial dysfunction protection, providing high-precision, reproducible data for advanced mitochondrial repair and organ anti-aging research.
Key Advantages
High-Concentration Mitochondrial Targeting: The 50mg high-dose formulation supports saturated cardiolipin binding research, mitochondrial inner membrane structure and respiratory chain supercomplex stability locking studies, and mitochondrial repair capabilities that exceed all low-to-medium dose SS-31 specification ranges.
Source-Level Antioxidant Protection: Possesses endogenous ROS burst inhibition and oxidative cascade free radical scavenging capabilities, supporting severe oxidative damage intervention research that exceeds conventional saturated dose ranges, representing advanced source-level antioxidant efficacy for SS-31 peptides.
Five-Dimensional Multi-Organ Repair Synergy: Integrates mitochondrial structure reconstruction, energy metabolism optimization, oxidative free radical scavenging, anti-apoptosis protection, and advanced anti-degeneration efficacy, providing comprehensive multi-organ repair research capabilities.
Mitochondrial Energy Metabolism Support: Supports mitochondrial membrane potential stabilization research, respiratory chain supercomplex structure maintenance, and ATP energy synthesis efficiency enhancement studies under severe oxidative stress conditions.
High-Purity Process and Quality Control: Employs advanced multi-stage gradient deep purification and low-temperature vacuum lyophilization technology, preserving active peptide structure with minimal impurity content. Packaged as 10 vials per dust-free aseptic pack, fully tested for purity by HPLC, and accompanied by a complete Certificate of Analysis (COA), suitable for high-standard advanced laboratory research and premium bulk custom procurement.
Specifications and Quality Control
Format: Lyophilized powder, 50mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).